Skip to main content

Table 1 The basic characteristics of the included studies

From: Network meta-analysis of invasive treatment for early-stage osteonecrosis of the femoral head

Author

Year

Region

Population

Age (mean, SD)

Gender (♀, ♂)

Ficat grade

ARCO stage

HHS (mean, SD)

Comparisons

Cao

2017

China

21

31, 6

5, 16

NA

I, 5/II, 26/III, 11

60, 8.03

CD versus BG

Aggarwal

2020

India

40

NA

3, 37

I, 13/II, 40

I, 13/II, 40

63.49, 8.04

CD versus CD + PRP

Li

2016

China

39

36.5

12, 27

I, 21/II, 26

NA

63.71, 3.58

BG versus CD + BG

Gangji

2011

Belgium

19

45.7, 2.8

10, 9

NA

I, 4/II, 20

NA

CD versus CD + BMMSC

Fu

2022

China

40

38.98, 3.95

11, 29

NA

I, 27/II, 13

77.73, 2.67

CD versus CD + BMMSC

Ma

2014

China

43

35.22, 9.66

11, 28

I, 7/II, 32/III, 10

NA

NA

CD + BG versus CD + BG + BMMSC

Hauzeur

2018

Belgium

38

48.85, 3.09

11, 27

NA

III, 46

NA

CD versus CD + BMMSC

Rastogi

2013

India

40

33.84, 7.36

11, 29

NA

I, 14/II, 22/III, 24

46.92, 1.70

CD + BG versus CD + BMMSC

Zhao

2012

China

100

33.25, 9.18

47, 53

NA

I, 5/II, 99

42.75, 4.50

CD versus CD + BMMSC

Tabatabaee

2015

Iran

28

28.9, 9.13

9, 19

NA

I, 5/II, 16/III, 7

NA

CD versus CD + BMMSC

Sen

2012

India

40

NA

13, 27

NA

I, II, 51

65.96, 14.02

CD versus CD + BMMSC

Chang

2010

China

8

35.7

1, 7

NA

II, 14/III, 2

56.19, 8.60

CD versus CD + BMMSC

Chen

2016

China

71

38.39, 10.11

27, 44

I, II, 51/III, 20

NA

39.63, 5.9

CD versus CD + SAI

Wang

2017

China

30

NA

11, 19

NA

I, 17/II, 22

NA

CD versus CD + BG

Yu

2014

China

48

37.77, 8.39

33, 15

NA

I, 9/II, 41/III, 23

52.96, 6.88

CD versus CD + BMMSC

  1. CD Core decompression, BG Bone grafting, PRP Platelet-rich plasma, BMMSC Bone marrow mesenchymal stem cells, SAI Superselective arterial infusion